Can't wait for them to seek regulatory approvals for cartilage and tendon growth - possible diversification in revenue will improve valuations.
Also like the fact that they are open to:
1) Sports segment - as I said in my previous post that market still uses the traditional methods, and
2) Animal health (not a focus of many companies)
All this will support SP - only they need to go find that CASH now.
Can't wait for them to seek regulatory approvals for cartilage...
-
- There are more pages in this discussion • 20 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
